US2005054873A1PendingUtilityA1
Process for the preparation of aniline-derived thyroid receptor ligands
Priority: Nov 2, 2001Filed: Sep 8, 2004Published: Mar 10, 2005
Est. expiryNov 2, 2021(expired)· nominal 20-yr term from priority
C07C 309/65C07C 45/00C07C 205/12C07C 205/37C07C 205/38C07C 205/43C07C 231/02C07C 233/25C07C 309/24C07C 201/12C07C 213/02
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are processes for the synthesis of aniline derivatives, specifically certain aniline derivatives which have activity as thyroid receptor ligands.
Claims
exact text as granted — not AI-modified1 - 27 . (cancel)
28 . A compound of formula IIA
wherein
R 2 and R 3 independently represent bromo, chloro, or methyl;
R 4 represents hydrogen or methyl; and
L represents mesyl, tosyl, p-nitrobenzenesulfonyl, trihaloacetate, or triflate.
29 . The compound according to claim 28 , selected from the group consisting of trifluoro-methanesulfonic acid 2,6-dibromo-4-nitrophenyl ester, trifluoro-methanesulfonic acid 2,6-dibromo-3-methyl-4-nitrophenyl ester, trifluoro-methanesulfonic acid 2,6-dichloro-4-nitrophenyl ester, and trifluoro-methanesulfonic acid 2,6-dichloro-3-methyl-4-nitrophenyl ester.
30 . The compound according to claim 28 , trifluoro-methanesulfonic acid 2,6-dibromo-4-nitrophenyl ester.
31 . A compound of formula IIIA
wherein
R 2 and R 3 independently represent bromo, chloro, or methyl; and
R 4 represents hydrogen or methyl.
32 . The compound according to claim 31 , selected from the group consisting of l,3-dibromo-2-iodo-5-nitrobenzene, 1,3-dibromo-2-iodo-4-methyl-5-nitrobenzene, 1,3-dichloro-2-iodo-5-nitrobenzene, and 1,3-dichloro-2-iodo-4-methyl-5-nitrobenzene.
33 . The compound according to claim 31 , 1,3-dibromo-2-iodo-5-nitrobenzene.
34 . A process for the synthesis of a phenol of formula A
wherein
G is a protecting group; and
R 1 represents halogen, trifluoromethyl, an alkyl group of 1 to 6 carbons, or a cycloalkyl group of 3 to 7 carbons;
comprising the steps of:
a) reacting an aldehyde of formula A-I with MHSO 3 to form a sulfonate of formula A-II
wherein M is a metal; and
b) reacting the sulfonate-of formula A-II with an oxidant, in the presence of a proton source, to form the phenol of formula A[, above].
35 . A compound selected from the group consisting of compounds of formula A-I and formula A-II,
wherein
G represents a protecting group;
M represents a metal; and
R 1 represents halogen, trifluoromethyl, an alkyl group of 1 to 6 carbons, or a cycloalkyl group of 3 to 7 carbons.
36 . The compound according to claim 35 , 3-isopropyl-4-methoxybenzaldehyde.
37 . The compound according to claim 35 , hydroxy-(3-isopropyl-4-methoxyphenyl)methanesulfonic acid, sodium salt.
38 . A compound of formula A
wherein
G represents a protecting group; and
R 1 represents halogen, trifluoromethyl, an alkyl group of 1 to 6 carbons, or a cycloalkyl group of 3 to 7 carbons;
with the proviso that, when G is a methyl group, R 1 is not a member of the group consisting of bromo, chloro, iodo, t-butyl, cyclohexyl, cyclopentyl, and isopropyl.Join the waitlist — get patent alerts
Track US2005054873A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.